(Bold for FDA approved)
How Clopixol works• Blocks dopamine 2 receptors, reducing positive symptoms of psychosis
• For injection, psychotic symptoms can improve within a few days, but it may take 1–2 weeks for notable improvement
• For oral formulation, psychotic symptoms can improve within 1 week, but may take several weeks for full effect on behavior
Notable Side Effects• Drug-induced parkinsonism
• Tardive dyskinesia (risk increases with duration of treatment and with dose)
• Risk of potentially irreversible involuntary dyskinetic movements may increase with cumulative dose and treatment duration
• Priapism
• Galactorrhea, amenorrhea
• Rare lens opacity
• Sedation, dizziness
• Dry mouth, constipation, vision problems
• Hypotension
• Weight gain
Life Threatening Side Effects• Rare neuroleptic malignant syndrome may cause hyperpyrexia, muscle rigidity, delirium, and autonomic instability with elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure
• Rare neutropenia
• Rare respiratory depression
• Rare agranulocytosis
• Rare seizures
• As a class, antipsychotics are associated with an increased risk of death and cerebrovascular events in elderly patients with dementia; not approved for treatment of dementia-related psychosis

common

common
• Wait
• Wait
• Wait
• For drug-induced parkinsonism, add an anticholinergic agent
• Beta blockers, benzodiazepines, or serotonin 2A antagonists (e.g.,mirtazapine, cyproheptadine) may reduce akathisia
• Reduce the dose
• For sedation, take at night
• Switch to an atypical antipsychotic
• Weight loss, exercise programs, and medical management for high BMIs, diabetes, dyslipidemia
• Metformin may help prevent or reverse antipsychotic-induced weight gain
• Oral 20–60 mg/day
• Acetate 50–150 mg every 2–3 days
• Decanoate 150–300 mg every 2–4 weeks
Dosage Forms• Tablet 10 mg, 25 mg, 40 mg
• Acetate 50 mg/mL (equivalent to zuclopenthixol 45.25 mg/mL), 100 mg/2 mL (equivalent to zuclopenthixol 45.25 mg/mL)
• Decanoate 200 mg/mL (equivalent to zuclopenthixol 144.4 mg/mL), 500 mg/mL (equivalent to zuclopenthixol 361.1 mg/mL)
• Zuclopenthixol decanoate is intended for maintenance treatment
• Should periodically reevaluate long-term usefulness in individual patients, but treatment may need to continue for many years
• No
Renal Impairment• Use with caution
Hepatic Impairment• Use with caution
Cardiac Impairment• Use with caution
Elderly• Some patients may tolerate lower doses better
• Maximum acetate dose 100 mg
• Although conventional antipsychotics are commonly used for behavioral disturbances in dementia, no agent has been approved for treatment of elderly patients with behavioral symptoms of dementia such as agitation
• Elderly patients with dementia-related psychosis treated with antipsychotics are at an increased risk of death compared to placebo, and also have an increased risk of cerebrovascular events
Children and Adolescents• Safety and efficacy have not been established in children under age 18
• Preliminary open-label data show that oral zuclopenthixol may be effective in reducing aggression in mentally impaired children
Pregnancy• Not recommended for use during pregnancy
• There is a risk of abnormal muscle movements and withdrawal symptoms in newborns whose mothers took an antipsychotic during the third trimester; symptoms may include agitation, abnormally increased or decreased muscle tone, tremor, sleepiness, severe difficulty breathing, and difficulty feeding
• Psychotic symptoms may worsen during pregnancy and some form of treatment may be necessary
• Atypical antipsychotics may be preferable to conventional antipsychotics or anticonvulsant mood stabilizers if treatment is required during pregnancy
Breast Feeding• Some drug is found in mother’s breast milk
• Recommended either to discontinue drug or bottle feed
• Infants of women who choose to breast feed should be monitored for possible adverse effects
Based on data Published online by Cambridge University Press
Compiled by Dr. Jash Ajmera